Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?
about
A review of the epidemiological evidence for the 'antioxidant hypothesis'The nitric oxide donor pentaerythritol tetranitrate can preserve endothelial function in established atherosclerosis4-Hydroperoxy-2-nonenal is not just an intermediate but a reactive molecule that covalently modifies proteins to generate unique intramolecular oxidation products.Chance and serendipity in science: two examples from my own career.Diet in childhood and adult cardiovascular and all cause mortality: the Boyd Orr cohort.Protective role of heme oxygenase in the blood vessel wall during atherogenesis.Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis'.Oxidized low-density lipoprotein.Realism in evidence based medicine: interpreting the randomised controlled trial.Antiatherogenic effects of the antioxidant BO-653 in three different animal models.Vitamins and cardiovascular disease.Effect of vitamins C and E on insulin resistance in diabetes: a meta-analysis study.Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease.High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance.Additional benefit in CVD risk indices derived from the consumption of fortified milk when combined with a lifestyle intervention.Antioxidant vitamin intake and subclinical coronary atherosclerosis.Periodontal health improves systemic inflammatory and haemostatic status in subjects with coronary heart disease
P2860
Q28262560-E2405D23-1FE1-4DF8-815C-86BA5386D915Q28363031-B5FB35D9-A128-490F-8718-96E14BEA217AQ35310202-D80FAED1-7E10-4B55-A775-50B5824ACDF8Q35516016-750EDAE1-B490-477D-9C4B-15AD61C0217BQ35584392-4DC713AE-0D07-444F-A249-63BED5EE5D15Q35794768-99ABD6CC-667E-424F-B2A7-C56BB352E9AAQ35837905-55A9FD9F-C37B-4B4F-BE43-A2D9CEBEED41Q35860737-5040B04C-9428-4A36-9D7C-7CF22C5059D6Q35887072-49BEBB2A-3E01-41F0-97D0-5EBE6F89A484Q36286332-BFDD4367-9F10-4344-9AB8-F9A30D026846Q37282850-762B8EB4-7726-41E1-8954-4D87837D3586Q38574961-795A09E3-D9DF-4AF0-9025-1302D6A92614Q46607739-0DFEFDC8-46CD-4ACB-8710-18090FBD3662Q46673641-E756848C-CD64-4682-94A7-547421E1BB19Q50887709-471C70E3-D6F3-40CC-A9EB-309940563FAAQ53543480-37CC4011-5221-4853-BC70-CAEA822DC0BBQ57000502-157E4F3C-05EB-4366-8DE1-CA103F552236
P2860
Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?
@en
type
label
Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?
@en
prefLabel
Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?
@en
P1433
P1476
Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?
@en
P2093
D Steinberg
P356
10.1016/S0140-6736(95)92657-7
P407
P577
1995-07-01T00:00:00Z